| 1 |
Cong YY, Fan B, Zhang ZY, Li GY. Implantable sustained-release drug delivery systems: a revolution for ocular therapeutics. Int Ophthalmol 2023. [PMID: 36715956 DOI: 10.1007/s10792-023-02637-x] [Reference Citation Analysis]
|
| 2 |
Dubashynskaya NV, Bokatyi AN, Golovkin AS, Kudryavtsev IV, Serebryakova MK, Trulioff AS, Dubrovskii YA, Skorik YA. Synthesis and Characterization of Novel Succinyl Chitosan-Dexamethasone Conjugates for Potential Intravitreal Dexamethasone Delivery. Int J Mol Sci 2021;22:10960. [PMID: 34681619 DOI: 10.3390/ijms222010960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Bufton J, Jung S, Evans JC, Bao Z, Aguiar D, Allen C. Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel. European Journal of Pharmaceutical Sciences 2021;162:105808. [DOI: 10.1016/j.ejps.2021.105808] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Lorenzo-Veiga B, Alvarez-Lorenzo C, Loftsson T, Sigurdsson HH. Age-related ocular conditions: Current treatments and role of cyclodextrin-based nanotherapies. Int J Pharm 2021;603:120707. [PMID: 33991594 DOI: 10.1016/j.ijpharm.2021.120707] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 5 |
Dubashynskaya NV, Bokatyi AN, Skorik YA. Dexamethasone Conjugates: Synthetic Approaches and Medical Prospects. Biomedicines 2021;9:341. [PMID: 33801776 DOI: 10.3390/biomedicines9040341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Adeleke OA. In vitro characterization of a synthetic polyamide-based erodible compact disc for extended drug release. SN Appl Sci 2020;2:2152. [DOI: 10.1007/s42452-020-03954-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 7 |
Collins M, Awwad S, Ibeanu N, Khaw PT, Guiliano D, Brocchini S, Khalili H. Dual-acting therapeutic proteins for intraocular use. Drug Discov Today 2021;26:44-55. [PMID: 33137484 DOI: 10.1016/j.drudis.2020.10.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 8 |
Bisht R, Nirmal S, Agrawal R, Jain GK, Nirmal J. Injectable in-situ gel depot system for targeted delivery of biologics to the retina. J Drug Target 2021;29:46-59. [PMID: 32729731 DOI: 10.1080/1061186X.2020.1803886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Awwad S, Henein C, Ibeanu N, Khaw PT, Brocchini S. Preclinical challenges for developing long acting intravitreal medicines. European Journal of Pharmaceutics and Biopharmaceutics 2020;153:130-49. [DOI: 10.1016/j.ejpb.2020.05.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 10 |
Tayyab H, Ahmed CN, Sadiq MAA. Efficacy and safety of Suprachoroidal Triamcinolone Acetonide in cases of resistant diabetic Macular Edema. Pak J Med Sci 2020;36:42-7. [PMID: 32063929 DOI: 10.12669/pjms.36.2.1194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
